DK246586A - Laegemiddel paa basis af alfuzosin - Google Patents

Laegemiddel paa basis af alfuzosin Download PDF

Info

Publication number
DK246586A
DK246586A DK246586A DK246586A DK246586A DK 246586 A DK246586 A DK 246586A DK 246586 A DK246586 A DK 246586A DK 246586 A DK246586 A DK 246586A DK 246586 A DK246586 A DK 246586A
Authority
DK
Denmark
Prior art keywords
alfuzosin
pharmaceutical form
pharmaceutical
Prior art date
Application number
DK246586A
Other languages
English (en)
Other versions
DK246586D0 (da
DK168029B1 (da
Inventor
Francois Regnier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9319589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK246586(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthelabo filed Critical Synthelabo
Publication of DK246586D0 publication Critical patent/DK246586D0/da
Publication of DK246586A publication Critical patent/DK246586A/da
Application granted granted Critical
Publication of DK168029B1 publication Critical patent/DK168029B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK246586A 1985-05-28 1986-05-27 Anvendelse af alfuzosin til fremstilling af laegemidler DK168029B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8507950 1985-05-28
FR8507950A FR2582513B1 (fr) 1985-05-28 1985-05-28 Compositions pharmaceutiques contenant de l'alfuzosine

Publications (3)

Publication Number Publication Date
DK246586D0 DK246586D0 (da) 1986-05-27
DK246586A true DK246586A (da) 1986-11-29
DK168029B1 DK168029B1 (da) 1994-01-24

Family

ID=9319589

Family Applications (1)

Application Number Title Priority Date Filing Date
DK246586A DK168029B1 (da) 1985-05-28 1986-05-27 Anvendelse af alfuzosin til fremstilling af laegemidler

Country Status (12)

Country Link
US (1) US4661491A (da)
EP (1) EP0204597B1 (da)
JP (1) JPS61277620A (da)
AU (1) AU586684B2 (da)
CA (1) CA1261755A (da)
DE (1) DE3683318D1 (da)
DK (1) DK168029B1 (da)
FR (1) FR2582513B1 (da)
HU (1) HUT46221A (da)
IE (1) IE58595B1 (da)
IL (1) IL78934A (da)
ZA (1) ZA863957B (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694495B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Préparation pharmaceutique transdermique contenant de l'alfuzosine.
WO1994008040A1 (en) * 1992-09-25 1994-04-14 Synaptic Pharmaceutical Corporation Dna encoding human alpha 1 adrenergic receptors and uses thereof
CA2145182C (en) 1992-09-25 2001-09-18 Jonathan A. Bard Dna encoding human alpha 1 adrenergic receptors and uses thereof
WO1994009371A1 (en) * 1992-10-09 1994-04-28 Massachusetts Institute Of Technology Antemortem diagnostic test for alzheimer's disease
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
WO1997017967A1 (en) * 1995-11-15 1997-05-22 Merck & Co., Inc. ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
FR2752737B1 (fr) * 1996-08-29 1998-10-02 Synthelabo Comprime a liberation controlee de chlorhydrate d'alfuzosine
KR100364328B1 (ko) * 1996-08-29 2002-12-26 사노피-신델라보 알푸조신 염산염의 제어방출 정제
US5922722A (en) * 1996-11-12 1999-07-13 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6057350A (en) * 1997-06-18 2000-05-02 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6037354A (en) 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6376503B1 (en) 1997-06-18 2002-04-23 Merck & Co., Inc Alpha 1a adrenergic receptor antagonists
US6214832B1 (en) 1997-06-18 2001-04-10 Merck & Co., Inc. Bis-piperidinyl-pyrimidin-2-ones as alpha 1a adrenergic receptor antagonists
US6080760A (en) * 1997-06-18 2000-06-27 Merck & Co., Inc. Alpha 1A adrenergic receptor antagonists
US6143750A (en) * 1997-06-18 2000-11-07 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
AU5234899A (en) 1998-07-30 2000-02-21 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
WO2000025782A1 (en) 1998-10-29 2000-05-11 Merck & Co., Inc. Dihydropyridinones and pyrrolinones useful as alpha 1a adrenoceptor antagonists
US6319932B1 (en) 1998-11-10 2001-11-20 Merck & Co., Inc. Oxazolidinones useful as alpha 1A adrenoceptor antagonists
US6228870B1 (en) 1998-11-10 2001-05-08 Merck & Co., Inc. Oxazolidinones useful as alpha 1a adrenoceptor antagonists
AU1345600A (en) 1998-11-12 2000-06-05 Merck & Co., Inc. Pyrimidinedione derivatives useful as alpha 1a adrenoceptor antagonists
US6358959B1 (en) 1999-01-26 2002-03-19 Merck & Co., Inc. Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists
GB2355457A (en) 1999-09-30 2001-04-25 Merck & Co Inc Novel spirotricyclic substituted azacycloalkane derivatives useful as alpha 1a adrenoceptor antagonists
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
GB2355263A (en) 1999-09-30 2001-04-18 Merck & Co Inc Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists
GB2355456A (en) 1999-09-30 2001-04-25 Merck & Co Inc Novel arylhydantoin derivatives useful as alpha 1a adrenoceptor antagonists
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
US20090069562A1 (en) * 2005-12-26 2009-03-12 Joseph Prabahar Koilpillai Process for the preparation of alfuzosin
WO2008073388A2 (en) * 2006-12-11 2008-06-19 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making and methods of use
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
EP2042179A1 (en) * 2007-09-26 2009-04-01 sanofi-aventis Novel therapeutic uses of adrenergic alpha-1 receptor antagonists
WO2010083360A2 (en) * 2009-01-16 2010-07-22 Mutual Pharmaceutical Company, Inc. Controlled-release formulations
ME02153B (me) 2011-09-19 2015-10-20 Orexo Ab Nove farmaceutske kompozicije, otporne na zloupotrebu, za tretman zavisnosti od opioida
US20160361380A1 (en) 2015-06-12 2016-12-15 Nymox Corporation Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
CN113599385B (zh) * 2021-08-20 2023-01-03 兰州大学 阿夫唑嗪在制备治疗糖尿病及其并发症药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
FR2466462A2 (fr) * 1978-02-06 1981-04-10 Synthelabo Derives d'alkylenediamines, leur preparation et leur application en therapeutique
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants

Also Published As

Publication number Publication date
HUT46221A (en) 1988-10-28
ZA863957B (en) 1987-01-28
IL78934A (en) 1991-01-31
FR2582513B1 (fr) 1988-08-05
CA1261755A (en) 1989-09-26
JPH0564930B2 (da) 1993-09-16
IL78934A0 (en) 1986-09-30
AU5795186A (en) 1986-12-04
DE3683318D1 (de) 1992-02-20
FR2582513A1 (fr) 1986-12-05
DK246586D0 (da) 1986-05-27
DK168029B1 (da) 1994-01-24
EP0204597B1 (fr) 1992-01-08
EP0204597A3 (en) 1989-08-16
EP0204597A2 (fr) 1986-12-10
US4661491A (en) 1987-04-28
IE58595B1 (en) 1993-10-20
IE861395L (en) 1986-11-28
JPS61277620A (ja) 1986-12-08
AU586684B2 (en) 1989-07-20

Similar Documents

Publication Publication Date Title
DK246586D0 (da) Laegemiddel paa basis af alfuzosin
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
DK180790D0 (da) Fremstilling af farmaceutisk praeparat
DK155419C (da) Bloed boernebaerer af posetypen
DK376087A (da) Behandling af emulsioner
MX162970B (es) Banda dentada mejorada
DK487085A (da) Forbindelser til induktion af cytokindannelse
DK237187D0 (da) Farmaceutisk anvendelse af t-pa
DK193588D0 (da) Anvendelser af dopaminagonister
DK382486A (da) Fremgangsmaade til fremstilling af sphingosinderivater
DK587A (da) Rensning af zirkonforbindelser
DK418386D0 (da) Kombinationspraeparat til behandling af malaria
DK564886D0 (da) Fungicid anvendelse af tetrahydrobenzothienylurinstofderivater
DK516286D0 (da) Fremgangsmaade til fremstilling af oxazolderivater
DK316589D0 (da) Substituerede azacyclohexylderivater af rifamyciner
DK210586D0 (da) Fremgangsmaade til sammensvejsning af roerformede plastgenstande
DK258886A (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK559786D0 (da) Mellemprodukter til fremstilling af beta-lactamantibiotika
DK233487D0 (da) Oxygeneret perfluoreret perfusion af oejeaeblet
DK509986D0 (da) Fremgangsmaade til fremstilling af aryl-cyanamider
DK163830C (da) Fremgangsmaade til fremstilling af riboflavin
ES541064A0 (es) Lentes conicas
DK28386D0 (da) Fremstilling af peptider
SE8503858D0 (sv) Novel pharmaceutical applications
DK61091A (da) Fremgangsmaade til fremstilling af 4-phenylpiperidinderivater

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired